Quantcast

After Hours Most Active for Mar 14, 2018 : QQQ, FOLD, F, MSFT, QEP, GM, USMC, BEN, CMCSA, BSX, CNP, EXEL


Shutterstock photo

The NASDAQ 100 After Hours Indicator is down -1.69 to 7,039.29. The total After hours volume is currently 45,970,192 shares traded.



The following are the most active stocks for the after hours session :



PowerShares QQQ Trust, Series 1 ( QQQ ) is -0.14 at $171.54, with 4,356,781 shares traded. This represents a 32.57% increase from its 52 Week Low.

Amicus Therapeutics, Inc. ( FOLD ) is unchanged at $15.17, with 3,480,203 shares traded. As reported by Zacks, the current mean recommendation for FOLD is in the "strong buy range".

Ford Motor Company ( F ) is +0.01 at $11.03, with 3,334,012 shares traded. F's current last sale is 84.85% of the target price of $13.

Microsoft Corporation ( MSFT ) is +0.04 at $93.89, with 2,375,771 shares traded. As reported by Zacks, the current mean recommendation for MSFT is in the "buy range".

QEP Resources, Inc. ( QEP ) is unchanged at $9.40, with 2,073,689 shares traded. As reported by Zacks, the current mean recommendation for QEP is in the "buy range".

General Motors Company ( GM ) is unchanged at $37.69, with 1,892,326 shares traded. GM's current last sale is 73.9% of the target price of $51.

Principal U.S. Mega-Cap Multi-Factor Index ETF ( USMC ) is -0.005 at $26.55, with 1,550,000 shares traded. This represents a 7.08% increase from its 52 Week Low.

Franklin Resources, Inc. ( BEN ) is unchanged at $38.86, with 1,542,016 shares traded. BEN's current last sale is 88.32% of the target price of $44.

Comcast Corporation ( CMCSA ) is unchanged at $36.02, with 1,405,200 shares traded. As reported by Zacks, the current mean recommendation for CMCSA is in the "buy range".

Boston Scientific Corporation ( BSX ) is unchanged at $28.01, with 1,401,227 shares traded. As reported by Zacks, the current mean recommendation for BSX is in the "buy range".

CenterPoint Energy, Inc. ( CNP ) is unchanged at $27.05, with 1,323,602 shares traded. CNP's current last sale is 96.61% of the target price of $28.

Exelixis, Inc. ( EXEL ) is -0.0181 at $24.85, with 1,161,379 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Mar 2018. The consensus EPS forecast is $0.13. As reported by Zacks, the current mean recommendation for EXEL is in the "buy range".

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , After Hours Most Active



More from NASDAQ.com News

Subscribe






NASDAQ.com News
Contributor:

NASDAQ.com News

Market News










Research Brokers before you trade

Want to trade FX?